Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Noha Mansour
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Eligible patients were 18 years or older.
2. Confirmed diagnosis of breast cancer.
3. Patients completed adriamycin and cyclophosphamide (AC) regimen and are planned to receive four cycles or more of paclitaxel chemotherapy with G-CSF support starting in cycle 1 and continuing throughout each of the four paclitaxel cycles.
4. Eastern Cooperative Oncology Group (ECOG) performance status from 0 to 2.
You may not be if
1. Patients with signs and symptoms of grade 2 or 3 bone pain at baseline.
2. Patients receiving famotidine in the previous 72 hours.
3. Patient receiving any antihistaminic in the previous 72 hours.
4. Hypersensitivity to famotidine or loratadine.
5. Patient receiving opioid or adjuvant analgesic.
Clareo Health | Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients
